There is a big gap between the narrowly focused data gathered in clinical trials and the lower-quality but more plentiful “real world data” routinely collected in clinical records, insurance...
Nine drug companies and six universities have now joined an unusual collaboration to break the logjam in research on acute myeloid leukemia (AML), a blood cancer lacking effective treatments....
Researchers have identified many of the altered genes and cell signaling pathways that drive papillary renal cell carcinoma, a poorly understood form of cancer that accounts for about 15 percent of...